BLISSGVS₹623.35-3.01%
76/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %BLISSGVS financial summary
For Mar 2026, Bliss GVS Pharma Ltd reported revenue of ₹730 crore, which grew 9.4% from the previous year. Net profit was ₹97 crore, which grew 40.6% year on year, on an operating margin of 18%. Earnings per share came in at ₹9.16. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹730 crore |
|---|---|
| Net profit | ₹97 crore |
| Operating margin | 18% |
| EPS | ₹9.16 |